findmyKOL
Clinical trialNCT05750498RecruitingObservational

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

SponsorChildren's Hospital Medical Center, CincinnatiEnrollment800Autoimmune HepatitisPrimary Sclerosing Cholangitis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The Autoimmune Liver disease Network for Kids (A-LiNK) is a multi-institutional group with the mission to deliver the best care to kids with pediatric autoimmune liver disease (AILD). This study will establish a shared clinical registry and a learning health network for the participating sites focusing on collecting and transmitting clinical measurement data, information about processes, and participation in an improvement collaborative. Pediatric Autoimmune Hepatitis (AIH) and Primary Sclerosing Cholangitis (PSC), represent a spectrum of AILD which present unique diagnostic and therapeutic challenges.A lack of accepted guidelines for disease monitoring or symptom management results in wide treatment variation with liver transplants indicated in refractory, progressive disease. The aims of A-LiNK are to: 1.) Create a learning health network focused on patient-centered outcomes research characterized by transparent sharing among centers, common priorities, and feasible plans for implementing new practices; 2) shift from traditional investigator-driven study to a patient and family-centered approach, and 3.) improve clinical outcomes and quality of life for pediatric AILD patients.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford University

    Palo Alto, California, United States

    Jennifer Halma, MDLeina Alrabadi, MD
    Recruiting
  • Riley Children'S Health

    Indianapolis, Indiana, United States

    Kyla Tolliver, MD
    Recruiting
  • St. Louis Children'S Hospital

    St Louis, Missouri, United States

    Sakil S Kulkarni, MD
    Recruiting
  • Cincinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

    Amy E Taylor, MD
    Recruiting
  • Nationwide Children'S Hospital

    Columbus, Ohio, United States

    Alexander Weymann, MD
    Recruiting
  • Upmc Children'S Hospital of Pittsburgh

    Pittsburgh, Pennsylvania, United States

    James E Squires, MDMary H Ayers, MD
    Recruiting
  • Ut Southwestern Medical Center

    Dallas, Texas, United States

    Sindhu Pandurangi, MD
    Recruiting
  • Seattle Children'S Hospital

    Seattle, Washington, United States

    Katelyn M Saarela, DO
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Apr 2022
Primary completion
31 Dec 2032
Completion
30 Jun 2033
Last update posted
19 Aug 2026
Registered enrollment
800
Registry id
NCT05750498

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.